Monday, 11 December 2017, 06:31:32 pm
Drug pricing committee meeting concludes
December 07, 2017

A two-day meeting of drug pricing committee concluded in Islamabad on Thursday.    

In a press statement issued after the meeting, the Drug Regulatory Authority clarified that increase in price of any drug was neither on the agenda nor any recommendation to this effect was made.      

Provision of innovative treatments and vaccines to the patients of Hepatitis A, B and C and cancer were discussed in the meeting.    

The meeting noted that marketing of generic drugs at reduced prices will enhance competition and availability of drugs in the market.